Business Trends– category –
-
Fate Therapeutics to Present on iPSC-Derived CAR T Cell Candidate FT819 for Autoimmune Diseases at 2026 Cantor Global Healthcare Conference
Stock Titan USA Overview Fate Therapeutics announced its participation in a fireside chat at the 2026 Cantor Global Healthcare Conference on September 9th, where it will discuss its off-the-shelf iPSC-derived CAR T cell candidate FT819 f... -
ESC Congress 2026 Reveals Breakthrough Gene Therapies for Cardiovascular Disease: AAV8 Reduces LDL-C by 80-90%, siRNA Kylo-11 Achieves 97% Lp(a) Reduction
HCPLive (YouTube) USA Overview Groundbreaking data on multiple gene and molecular therapies for cardiovascular disease were presented at ESC Congress 2026. An AAV8-mediated gene therapy for homozygous familial hypercholesterolemia (HoFH)... -
Fate Therapeutics Initiates Phase 1/2 Trial for Novel Cell Therapy FT839 in Autoimmune Diseases, Expanding Pipeline
TipRanks.com USA Overview Fate Therapeutics has launched a Phase 1/2 dose-escalation and expansion trial for its novel cell therapy candidate, FT839, in patients with autoimmune diseases. This intravenously administered therapy is design... -
Fate Therapeutics Initiates Phase 2 RECLAIM-LN Trial for Lupus Nephritis with Off-the-Shelf iPSC-Derived CD19 CAR-T Cell Therapy FT819
Seeking Alpha USA Overview Fate Therapeutics has commenced its Phase 2 RECLAIM-LN trial for lupus nephritis, administering the first patient with its iPSC-derived CD19 CAR-T cell therapy, FT819, in an outpatient setting. This marks a sig... -
August Sees Mixed Fortunes in Gene Therapy: Ultragenyx’s GSDIa Therapy Gets Accelerated Approval, Epicrispr Raises $90M, While REGENXBIO’s RGX-121 Faces Clinical Hold
Vertex AI Search USA Overview August 2026 brought both significant advancements and setbacks in the next-generation therapeutics space. Ultragenyx secured FDA accelerated approval for GENGLYCOS, a gene therapy for GSDIa, offering a new o... -
McGraw Hill Acquires AI Startup Teachally to Accelerate K-12 Curriculum Development and Teacher AI Tools
GeekWire USA Overview Educational publishing giant McGraw Hill has acquired Teachally, an AI startup that assists teachers in building and customizing lessons, assignments, and assessments aligned with state standards. This acquisition w... -
Surge in AI M&A: Life Sciences Sector Accelerates R&D Through AI Company Acquisitions
Fasken Canada Overview M&A activity in the AI industry is intensifying, particularly in the life sciences, where major medical and pharmaceutical companies are acquiring AI firms to accelerate R&D. As AI systems become integral t... -
Plan A Technologies Acquires AI Assessment Technology to Enhance Technical M&A Due Diligence
Pulse 2.0 USA Overview Plan A Technologies has acquired an advanced AI assessment technology to significantly upgrade its technical M&A due diligence capabilities. This acquisition enables rapid identification of technical debt and o... -
Microsoft Unveils “Copilot OS”: Integrates AI Agents Across Windows and Azure for Natural Language Task Management, Workflow Automation, and Enhanced Productivity
Microsoft Build News Center USA Overview Microsoft has introduced "Copilot OS," a deeply integrated AI agent layer unifying AI capabilities across Windows and Azure cloud services. This novel operating system paradigm empowers autonomous... -
Eastman Deploys Two Molecular Recycling Technologies, PRT and CRT, to Reduce Plastic Waste and Greenhouse Gas Emissions
Eastman USA Overview Eastman is deploying two innovative molecular recycling technologies, Polyester Renewal Technology (PRT) and Carbon Renewal Technology (CRT), to address the plastic waste crisis. PRT depolymerizes post-consumer polye...
